Yongli Song, Jie Li, Yating Zhang, Lingge Su, Shuang Qin, Chunyan Wu, Guibo Song
{"title":"耐碳青霉烯假单胞菌生物膜成熟受sRNA PA213及其编码小蛋白调控","authors":"Yongli Song, Jie Li, Yating Zhang, Lingge Su, Shuang Qin, Chunyan Wu, Guibo Song","doi":"10.1016/j.ijantimicag.2025.107625","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Biofilm formation is a key factor contributing to the persistence and resistance of carbapenem-resistant Pseudomonas aeruginosa (CRPA). This study aims to elucidate the regulatory role of PA213, a previously uncharacterized and hypoxia-inducible small RNA, in promoting CRPA biofilm maturation.</p><p><strong>Methods: </strong>We collected 113 clinical isolates for species identification and antimicrobial profiling. Comparative transcriptomic analyses were conducted between carbapenem-susceptible and resistant strains to identify functional sRNA candidates. The expression and structure of PA213 were characterized using qRT-PCR, RACE, and secondary structure prediction. A Flag-tagged PA213 fusion protein was confirmed by Western blot. PA213's phenotypic effects were assessed through assays of biofilm formation, motility, pyocyanin production, and extracellular matrix regulation. Biofilm architecture was visualized by SEM, and viability was analyzed via CFU counts and PI staining. Protein partners were identified via GST-pulldown and LC-MS, and interaction with OprI was confirmed through immunofluorescence and biochemical validation. The impact of PA213 on quorum sensing (QS) gene expression was examined by RT-qPCR based on RNA-seq datasets.</p><p><strong>Results: </strong>PA213 is a novel, uncharacterized sRNA that is highly expressed in clinical CRPA isolates. This sRNA featured a typical stem-loop structure and a 279-nucleotide open reading frame (ORF), which encoded a low-molecular-weight polypeptide. PA213 was significantly upregulated in clinical CRPA under hypoxia and encoded a small peptide with high conservation. Functionally, PA213 acted as a multifunctional regulator, enhancing biofilm formation, inhibiting pyocyanin synthesis, promoting swimming motility, and reducing virulence and pathogenicity. It enhanced biofilm formation during microcolony (12-48 h) and maturation (48-72 h) phases, without increasing EPS production or relying on the las/rhl QS pathway. It ensured sufficient functional bacterial density and maintained the three-dimensional structure of the biofilm by modulating viable bacterial proliferation. Mechanistically, the protein encoded by PA213 directly interacted with OprI, mediating spatial stabilization of mature biofilms.</p><p><strong>Conclusion: </strong>PA213 functions as a bifunctional sRNA-peptide regulator that promotes CRPA biofilm maturation via non-coding and protein-mediated mechanisms, offering new insights into hypoxia-responsive biofilm regulation and antimicrobial resistance evolution.</p>","PeriodicalId":13818,"journal":{"name":"International Journal of Antimicrobial Agents","volume":" ","pages":"107625"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biofilm Maturation in Carbapenem-resistant Pseudomonas aeruginosa Is Regulated by the sRNA PA213 and Its Corresponding Encoded Small Protein.\",\"authors\":\"Yongli Song, Jie Li, Yating Zhang, Lingge Su, Shuang Qin, Chunyan Wu, Guibo Song\",\"doi\":\"10.1016/j.ijantimicag.2025.107625\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Biofilm formation is a key factor contributing to the persistence and resistance of carbapenem-resistant Pseudomonas aeruginosa (CRPA). This study aims to elucidate the regulatory role of PA213, a previously uncharacterized and hypoxia-inducible small RNA, in promoting CRPA biofilm maturation.</p><p><strong>Methods: </strong>We collected 113 clinical isolates for species identification and antimicrobial profiling. Comparative transcriptomic analyses were conducted between carbapenem-susceptible and resistant strains to identify functional sRNA candidates. The expression and structure of PA213 were characterized using qRT-PCR, RACE, and secondary structure prediction. A Flag-tagged PA213 fusion protein was confirmed by Western blot. PA213's phenotypic effects were assessed through assays of biofilm formation, motility, pyocyanin production, and extracellular matrix regulation. Biofilm architecture was visualized by SEM, and viability was analyzed via CFU counts and PI staining. Protein partners were identified via GST-pulldown and LC-MS, and interaction with OprI was confirmed through immunofluorescence and biochemical validation. The impact of PA213 on quorum sensing (QS) gene expression was examined by RT-qPCR based on RNA-seq datasets.</p><p><strong>Results: </strong>PA213 is a novel, uncharacterized sRNA that is highly expressed in clinical CRPA isolates. This sRNA featured a typical stem-loop structure and a 279-nucleotide open reading frame (ORF), which encoded a low-molecular-weight polypeptide. PA213 was significantly upregulated in clinical CRPA under hypoxia and encoded a small peptide with high conservation. Functionally, PA213 acted as a multifunctional regulator, enhancing biofilm formation, inhibiting pyocyanin synthesis, promoting swimming motility, and reducing virulence and pathogenicity. It enhanced biofilm formation during microcolony (12-48 h) and maturation (48-72 h) phases, without increasing EPS production or relying on the las/rhl QS pathway. It ensured sufficient functional bacterial density and maintained the three-dimensional structure of the biofilm by modulating viable bacterial proliferation. Mechanistically, the protein encoded by PA213 directly interacted with OprI, mediating spatial stabilization of mature biofilms.</p><p><strong>Conclusion: </strong>PA213 functions as a bifunctional sRNA-peptide regulator that promotes CRPA biofilm maturation via non-coding and protein-mediated mechanisms, offering new insights into hypoxia-responsive biofilm regulation and antimicrobial resistance evolution.</p>\",\"PeriodicalId\":13818,\"journal\":{\"name\":\"International Journal of Antimicrobial Agents\",\"volume\":\" \",\"pages\":\"107625\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Antimicrobial Agents\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijantimicag.2025.107625\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Antimicrobial Agents","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijantimicag.2025.107625","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Biofilm Maturation in Carbapenem-resistant Pseudomonas aeruginosa Is Regulated by the sRNA PA213 and Its Corresponding Encoded Small Protein.
Objectives: Biofilm formation is a key factor contributing to the persistence and resistance of carbapenem-resistant Pseudomonas aeruginosa (CRPA). This study aims to elucidate the regulatory role of PA213, a previously uncharacterized and hypoxia-inducible small RNA, in promoting CRPA biofilm maturation.
Methods: We collected 113 clinical isolates for species identification and antimicrobial profiling. Comparative transcriptomic analyses were conducted between carbapenem-susceptible and resistant strains to identify functional sRNA candidates. The expression and structure of PA213 were characterized using qRT-PCR, RACE, and secondary structure prediction. A Flag-tagged PA213 fusion protein was confirmed by Western blot. PA213's phenotypic effects were assessed through assays of biofilm formation, motility, pyocyanin production, and extracellular matrix regulation. Biofilm architecture was visualized by SEM, and viability was analyzed via CFU counts and PI staining. Protein partners were identified via GST-pulldown and LC-MS, and interaction with OprI was confirmed through immunofluorescence and biochemical validation. The impact of PA213 on quorum sensing (QS) gene expression was examined by RT-qPCR based on RNA-seq datasets.
Results: PA213 is a novel, uncharacterized sRNA that is highly expressed in clinical CRPA isolates. This sRNA featured a typical stem-loop structure and a 279-nucleotide open reading frame (ORF), which encoded a low-molecular-weight polypeptide. PA213 was significantly upregulated in clinical CRPA under hypoxia and encoded a small peptide with high conservation. Functionally, PA213 acted as a multifunctional regulator, enhancing biofilm formation, inhibiting pyocyanin synthesis, promoting swimming motility, and reducing virulence and pathogenicity. It enhanced biofilm formation during microcolony (12-48 h) and maturation (48-72 h) phases, without increasing EPS production or relying on the las/rhl QS pathway. It ensured sufficient functional bacterial density and maintained the three-dimensional structure of the biofilm by modulating viable bacterial proliferation. Mechanistically, the protein encoded by PA213 directly interacted with OprI, mediating spatial stabilization of mature biofilms.
Conclusion: PA213 functions as a bifunctional sRNA-peptide regulator that promotes CRPA biofilm maturation via non-coding and protein-mediated mechanisms, offering new insights into hypoxia-responsive biofilm regulation and antimicrobial resistance evolution.
期刊介绍:
The International Journal of Antimicrobial Agents is a peer-reviewed publication offering comprehensive and current reference information on the physical, pharmacological, in vitro, and clinical properties of individual antimicrobial agents, covering antiviral, antiparasitic, antibacterial, and antifungal agents. The journal not only communicates new trends and developments through authoritative review articles but also addresses the critical issue of antimicrobial resistance, both in hospital and community settings. Published content includes solicited reviews by leading experts and high-quality original research papers in the specified fields.